Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

ent of metastatic breast cancer and is also in Phase 2 studies for the treatment of lung and brain cancers. In anti-infectives, Amikacin Inhale is in Phase 3 studies conducted by Bayer Healthcare as an adjunctive treatment for intubated and mechanically ventilated patients with Gram-negative pneumonia. Additional late-stage development products that leverage Nektar's proprietary technology platform include Baxter's BAX 855, a longer-acting rFVIII program, which is in Phase 3 clinical development for patients with hemophilia A.

Nektar's technology has enabled eight approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com

*Sources: Bell TJ et. al. Pain Med 2009;10(1):35-42, Hess B et. al. Eur J Intern Med 2011;22(5):527-531, Rosti G et. al Eur Rev Med Pharmacol Sci. 2010;14(12):1045-1050. Galvez R et. al. Aten Primaria 2014;46(1):32-39, Droney J et. al. Support Care Cancer 2008;16(5):453-459.

Movantik is a trademark of AstraZeneca.

Cautionary Note Regarding Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "expect," "believe," "should," "may," "will" and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the potential regulatory approval of Movantik&
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
(Date:5/22/2015)... -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" ... China based on the number ... Mr. Fuxiang Zhang as the Company,s Chief ... Rebecca Yingnan Zhang has been appointed as Chief ... immediately. Meanwhile, Ms. Zhang resigned from the position as ...
(Date:5/21/2015)... 2015  When Ryan Rendino first felt ... his neck, he figured it was a ... off from weight lifting. But ... A series of doctor appointments ... Michel Kliot, MD , a ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Comparing Gene Expression in Female and Male Patients Presented at ... Inc. (Nasdaq: GHDX ) today announced results from ... Onco type DX(R) breast cancer test in a large ... to guide treatment with chemotherapy. The results, which will be ...
... Evidence of Biological Activity in 9 of 12 Patients; ... Medical CentersSAN DIEGO, May 28 Celladon Corporation presented ... Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID), ... symposium at the 12th Annual American Society of Gene ...
Cached Medicine Technology:Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 2Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 3Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 4Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women 5Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 2Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 3Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting 4
(Date:5/22/2015)... India Network Foundation sponsors various community events ... India. India Network Visitor Health insurance is one ... help hundreds and thousands of families every year. ... by famous playback singer from Mumbai, Smt. Anuradha Paudwal ... Central Florida activities. , Anuradha Paudwal is ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Her popular Love ... the Hilton Hotel in San Gabriel on Saturday, May 23rd. ... over again from men and women who are unhappy in ... right partner." , "Many singles think that their biggest problem ... seeker would go from one relationship to another trying to ...
(Date:5/21/2015)... 2015 Absolute Exhibits, a trade ... state-of-the-art website that is filled with essential exhibiting tools ... information. With its original and inventive design ideas, it ... website shows hundred of pictures of client- owned or ... is not an exhibit rendering site, rather real-time pictures ...
(Date:5/21/2015)... Ticket Down is a reliable source for authentic ... Guatemala on Friday, July 3rd at LP Field in Nashville, ... fan of international soccer. The number of chances to watch some ... is growing at a large clip. Over the past several years, ... USA to play in front of the American people. The match ...
(Date:5/21/2015)... How do you stop head lice epidemics ... and school administrators, but a Miami Lice Removal Company, Lice ... southern Florida, is devising new ways to stop the spread. ... you, the first step is education and prevention. Despite the ... and how they spread are still widely misunderstood. Many continue ...
Breaking Medicine News(10 mins):Health News:India Network Visitor Health Insurance Announces Corporate Sponsorship of Anuradha Paudwal Musical in Orlando to Help Fundraise for Hindu Society of Central Florida. 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2Health News:New Convention and City Travel Guides Within the Absolute Exhibits’ Website 2Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2Health News:Local Lice Removal Company Partners with Schools to Combat Head Lice in the Classroom as Increase in Number of Cases Reported in May. 2
... chimpanzees is so much alike the code of humans, almost ... us. And yet, // there are glaring differences, despite the ... was not a different set of genes that caused the ... utilized. According to a latest theory on evolution, even small ...
... research has suggested that Women with disproportionate or uneven breasts ... mammography is designed to record any alterations or changes in ... University of Liverpool team conducted a study where mammograms of ... number of mammograms from healthy women. It was observed ...
... Von Eschenbach, nominated to run the U.S. Food and ... to political pressure while scientific decisions were being made//. ... effectiveness of medical endeavors, the appropriateness should also be ... administrator of the FDA and Director of National Cancer ...
... millions of people. Scientists at the University of Dundee have ... and asthma. ,This gene produces the protein filaggrin. ... the skin. It prevents bacteria and viruses from colonizing the ... skin from drying. Reduction or absence of the protein leads ...
... new light on the mechanism of nerve cell growth ... myosin-II, according to an //article in the March issue ... attempt to recover after damage, they extend growth cones, ... cones use the information they gather to direct advance ...
... check the mushrooming growth of beauty clinics in the ... ,"A Beauty Parlour Act will be sent to ... Sharma, chairperson of the rules and regulation committee of ... him, the decision to enact the act was taken ...
Cached Medicine News:Health News:FDA Nominee Says That He Is Not Influenced By Politics 2Health News:Gene That Causes Dry Skin, Identified 2Health News:A New Focus For The Mechanism Of Nerve Growth 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: